8-KOther Events

BOSTON SCIENTIFIC CORP 8-K Report, Corporate Update (Feb 23, 2017)

Filed February 23, 2017For Securities:BSX

Summary

Boston Scientific Corp. (BSX) announced on February 23, 2017, a voluntary global removal of all Lotus™ Valve devices, including those with Depth Guard™, from commercial and clinical use. This action is due to reports of a premature release issue with a pin connecting the valve to its delivery system, which the company attributes to excess tension during manufacturing. The company anticipates a return of the Lotus™ Valve platform to markets in Europe and other regions by the fourth quarter of 2017. Furthermore, Boston Scientific plans to file a U.S. Premarket Approval (PMA) submission for its next-generation Lotus Edge™ Valve System in the fourth quarter of 2017, targeting a mid-2018 U.S. launch. Investors should monitor the progress of these timelines and the company's ability to resolve the manufacturing issue.

Key Highlights

  • 1Voluntary global removal of all Lotus™ Valve devices due to a premature release issue with the delivery pin.
  • 2The issue is attributed to excess tension in the pin mechanism introduced during the manufacturing process.
  • 3Company expects the Lotus™ Valve platform to return to market in Europe and other regions in Q4 2017.
  • 4U.S. PMA submission for the next-generation Lotus Edge™ Valve System is planned for Q4 2017.
  • 5U.S. launch of the Lotus Edge™ Valve System is anticipated for mid-2018.
  • 6The announcement includes forward-looking statements regarding timelines, subject to potential risks and uncertainties.

Frequently Asked Questions

Boston Scientific is voluntarily removing all Lotus™ Valve devices globally due to reports of a premature release of a pin connecting the valve to the delivery system. The company believes this issue stems from excess tension in the pin mechanism during manufacturing.

Boston Scientific anticipates bringing the Lotus™ Valve platform back to market in Europe and other regions in the fourth quarter of 2017.

The company plans to file the U.S. Premarket Approval (PMA) submission for the Lotus Edge™ Valve System in the fourth quarter of 2017, with a targeted U.S. launch in mid-2018.

This specific 8-K filing (Item 8.01) primarily announces the voluntary product removal and provides updated timelines for product reintroduction and next-generation systems. It does not detail specific financial impacts or guidance related to this event.